6 Results for "

ligustilide

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "ligustilide" in MCE Product Catalog:

5
(Z)-Ligustilide
(Z)-Ligustilide
0 Images
5 Cited Publications
Cat. No.: HY-N0401A
CAS No.: 81944-09-4
Category:  

Natural Products Metabolic Disease Dicerothamnus rhinocerotis Plants Umbelliferae Disease Research Fields

Target:  

Bacterial Estrogen Receptor/ERR FATP

(Z)-Ligustilide is extracted from Ligusticum chuanxiong Hort, has antimicrobial and antifungal activity, exhibits an average antifungal score of 5.6 . (Z)-Ligustilide is orally active, it inhibits the expression of FATP5 and DGAT, inhibits fatty acid uptake and esterification in mice and has potential as therapeutics for nonalcoholic fatty liver disease (NAFLD) . (Z)-Ligustilide is also able to reactivate ERα, has epigenetic regulation, and is used in the study of tamoxifen-resistant breast cancer .
Ligustilide
Ligustilide
0 Images
Cat. No.: HY-N0401
CAS No.: 4431-01-0
Category:  

Cardiovascular Disease Natural Products Neurological Disease Dicerothamnus rhinocerotis Plants Umbelliferae Disease Research Fields Inflammation/Immunology Echinacea angustifolia DC.

Target:  

Autophagy Apoptosis

Ligustilide is is a bioactive phthalide derivative isolated from Angelica sinensis and Chuanxiong. Ligustilide exhibits neuroprotective, anti-cancer, anti-inflammatory, and vasodilator effects .
Senkyunolide I
Senkyunolide I
0 Images
Cat. No.: HY-N0745
CAS No.: 94596-28-8
Category:  

Natural Products Dicerothamnus rhinocerotis Plants Umbelliferae Disease Research Fields Inflammation/Immunology

Target:  

Caspase ERK Keap1-Nrf2 Heme Oxygenase (HO) Apoptosis

Senkyunolide I is an orally active, blood-brain barrier-permeable metabolite of Z-ligustilide (HY-N0401A) . Senkyunolide I is isolated from Ligusticum chuanxiong. Senkyunolide I upregulates p-Erk1/2 and Nrf2/HO-1, and inhibits Caspase 3. Senkyunolide I alleviates Apoptosis. Senkyunolide I increases the pain threshold in mice and reduces acetic acid-induced writhing responses in mice. Senkyunolide I improves neurological deficits, reduces infarct volume and alleviates cerebral edema in rats with focal cerebral ischemia-reperfusion injury. Senkyunolide I protects renal function and structural integrity in a mouse model of renal ischemia-reperfusion injury. Senkyunolide I is applicable to research related to focal cerebral ischemia-reperfusion injury, migraine, and renal ischemia-reperfusion injury .
(E)-Ligustilide
(E)-Ligustilide
0 Images
Cat. No.: HY-N0401B
CAS No.: 81944-08-3
Category:  

Natural Products Metabolic Disease Plants Umbelliferae Disease Research Fields Echinacea angustifolia DC.

Target:  

Others

(E)-Ligustilide is isolated from Angelica?sinensis and has nephroprotective?effects .
(Z)-Ligustilide-d7
(Z)-Ligustilide-d7
0 Images
Cat. No.: HY-N0401AS
(Z)-Ligustilide-d7 is the deuterium-labeled (Z)-Ligustilide (HY-N0401A) .
Angelica Extract
Angelica Extract
0 Images
Cat. No.: HY-N13219
Target:  

Others

Domaines de recherche:  

Metabolic Disease

Angelica Extract is an angelica extract, and its components include: Ligustilide. Angelica Extract can effectively inhibit the differentiation of osteoclasts, regulate osteoclastogenesis and/or bone loss. Angelica Extract has the potential to be used in the study of various bone diseases caused by excessive bone resorption. .
Assay Types